Literature DB >> 24364684

Options as information: rational reversals of evaluation and preference.

Shlomi Sher1, Craig R M McKenzie2.   

Abstract

This article develops a rational analysis of an important class of apparent preference reversals-joint-separate reversals traditionally explained by the evaluability hypothesis. The "options-as-information" model considers a hypothetical rational actor with limited knowledge about the market distribution of a stimulus attribute. The actor's evaluations are formed via a 2-stage process-an inferential stage in which beliefs are updated on the basis of the sample of options received, followed by an assessment stage in which options are evaluated in light of these updated beliefs. This process generates joint-separate reversals in standard experimental designs. The normative model explains why the evaluability hypothesis works when it does, identifies boundary conditions for the hypothesis, and clarifies some common misconceptions about these effects. In particular, it implies that joint-separate reversals are not irrational; in fact, they are not preference reversals. However, in expanded designs where more than 2 options are jointly evaluated, the model predicts that genuine (and rational) preference reversals will sometimes emerge. Results of 3 experiments suggest an excellent fit between the rational actor model and the judgments of human actors in joint-separate experiments. PsycINFO Database Record (c) 2014 APA, all rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24364684     DOI: 10.1037/a0035128

Source DB:  PubMed          Journal:  J Exp Psychol Gen        ISSN: 0022-1015


  2 in total

1.  Illusory inconsistencies in judgment: Stimulus-evoked reference sets and between-subjects designs.

Authors:  Lim M Leong; Craig R M McKenzie; Shlomi Sher; Johannes Müller-Trede
Journal:  Psychon Bull Rev       Date:  2019-04

2.  Irrational behavior in C. elegans arises from asymmetric modulatory effects within single sensory neurons.

Authors:  Shachar Iwanir; Rotem Ruach; Eyal Itskovits; Christian O Pritz; Eduard Bokman; Alon Zaslaver
Journal:  Nat Commun       Date:  2019-07-19       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.